Overview
Gemigliptin is under investigation in Type 2 Diabetes Mellitus. Gemigliptin has been investigated for the treatment of Cancer and Cisplatin Adverse Reaction.
Indication
No indication information available.
Associated Conditions
- Type 2 Diabetes Mellitus
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2022/12/23 | Phase 4 | Recruiting | |||
2022/01/18 | Phase 4 | Recruiting | Wonju Severance Christian Hospital | ||
2021/11/03 | Phase 1 | UNKNOWN | LG Chem | ||
2021/01/12 | Not Applicable | Completed | |||
2020/03/23 | Phase 1 | Completed | LG Chem | ||
2020/02/05 | Phase 3 | UNKNOWN | LG Chem | ||
2019/08/08 | Phase 1 | UNKNOWN | LG Chem | ||
2019/03/06 | Phase 1 | Completed | LG Chem | ||
2019/02/15 | Phase 3 | Completed | LG Chem | ||
2018/06/21 | Phase 1 | UNKNOWN | LG Chem |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.